153 related articles for article (PubMed ID: 17768830)
1. [Indications for immunoglobulins. Recommendations of CEDIT of AP-HP in 2006].
Guillevin L
Rev Med Interne; 2007 May; 28 Spec No. 1():1-3. PubMed ID: 17768830
[TBL] [Abstract][Full Text] [Related]
2. [Evolution of polyvalent intravenous immunoglobulins (IVIg) prescription, at the Assistance Publique - Hopitaux de Paris between 1988 and 1997. Results of the plan of action set up in order to regulate the prescription].
Courtay A; Couturon I; Charpentier E; Viens-Bitker C; Guillevin L; Etienne JP; Fery-Lemonnier E
Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S5-12. PubMed ID: 10896982
[TBL] [Abstract][Full Text] [Related]
3. Use of non-specific intravenous human immunoglobulins in Spanish hospitals; need for a hospital protocol.
Ruiz-Antorán B; Agustí Escasany A; Vallano Ferraz A; Danés Carreras I; Riba N; Mateu Escudero S; Costa J; Sánchez Santiago MB; Laredo L; Durán Quintana JA; Castillo JR; Abad-Santos F; Payares Herrera C; Sádaba Díaz de Rada B; Gómez Ontañón E
Eur J Clin Pharmacol; 2010 Jun; 66(6):633-41. PubMed ID: 20204337
[TBL] [Abstract][Full Text] [Related]
4. Use of intravenous immunoglobulins in clinical practice: data from three French university hospitals.
Frauger E; Grassi J; Pradel V; Bornet C; Rouby F; Delorme J; Ousset S; Braguer D; Azulay JP; Penot-Ragon C; Harle JR; Bongrand MC; Weiller PJ; Pouget J; Michel G; Micallef J; Reynier JP; Tardieu S; Vanelle P; Blin O;
Fundam Clin Pharmacol; 2011 Dec; 25(6):753-61. PubMed ID: 21219439
[TBL] [Abstract][Full Text] [Related]
5. [Immunoglobulins and physiopathology: actual indications].
Mouthon L; Guilpain P
Rev Med Interne; 2007 May; 28 Spec No. 1():11-7. PubMed ID: 17768833
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome.
Nosadini M; Mohammad SS; Suppiej A; Sartori S; Dale RC;
Dev Med Child Neurol; 2016 Nov; 58(11):1180-1192. PubMed ID: 27242065
[TBL] [Abstract][Full Text] [Related]
7. [The rational immunotherapy with intravenous immunoglobulin in neurologic diseases].
Korsak J
Pol Merkur Lekarski; 2011 Jun; 30(180):430-4. PubMed ID: 21751554
[TBL] [Abstract][Full Text] [Related]
8. Recommended indications for the administration of polyclonal immunoglobulin preparations.
Delforge M; Farber CM; Spath P; Kaveri S; Witte T; Misbah SA; Hübner R; Haerynck F; Latinne D; Muylle L; Toungouz M; Deneys V;
Acta Clin Belg; 2011; 66(5):346-60. PubMed ID: 22145269
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
Gürcan HM; Ahmed AR
Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
[TBL] [Abstract][Full Text] [Related]
10. An intravenous immunoglobulin therapy of serious autoimmune rheumatic diseases.
Lukan N; Lazurova I; Racz O; Kristofova B; Tkac I
Bratisl Lek Listy; 2008; 109(11):489-92. PubMed ID: 19205557
[TBL] [Abstract][Full Text] [Related]
11. Use of intravenous immunoglobulin G (IVIG).
Looney RJ; Huggins J
Best Pract Res Clin Haematol; 2006; 19(1):3-25. PubMed ID: 16377538
[TBL] [Abstract][Full Text] [Related]
12. European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology.
Enk AH; Hadaschik EN; Eming R; Fierlbeck G; French LE; Girolomoni G; Hertl M; Jolles S; Karpati S; Steinbrink K; Stingl G; Volc-Platzer B; Zillikens D
J Eur Acad Dermatol Venereol; 2016 Oct; 30(10):1657-1669. PubMed ID: 27406069
[TBL] [Abstract][Full Text] [Related]
13. The patient: Emerging clinical applications of intravenous immunoglobulin.
Harvey RD
Pharmacotherapy; 2005 Nov; 25(11 Pt 2):85S-93S. PubMed ID: 16229679
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin: striving for appropriate use.
Kumar A; Teuber SS; Gershwin ME
Int Arch Allergy Immunol; 2006; 140(3):185-98. PubMed ID: 16682800
[TBL] [Abstract][Full Text] [Related]
15. [Use of intravenous immunoglobulin preparations (IVIG) in treatment of primary cell immunodeficiencies].
Siwińska-Gołebiowska H; Czerwińska-Kartowicz I; Markiewicz K
Postepy Hig Med Dosw; 2002; 56 Suppl():33-40. PubMed ID: 12661412
[TBL] [Abstract][Full Text] [Related]
16. [European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology].
Hadaschik E; Eming R; French LE; Girolomoni G; Hertl M; Jolles S; Karpati S; Steinbrink K; Stingl G; Volc-Platzer B; Zillikens D; Enk A
Hautarzt; 2020 Jul; 71(7):542-552. PubMed ID: 32435817
[TBL] [Abstract][Full Text] [Related]
17. IVIG therapy in neurological disorders of childhood.
Archelos JJ; Fazekas F
J Neurol; 2006 Sep; 253 Suppl 5():V80-6. PubMed ID: 16998760
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic indications of intravenous immunoglobulins].
Tellier Z; Mouthon L
Transfus Clin Biol; 2003 Jun; 10(3):179-84. PubMed ID: 12798854
[TBL] [Abstract][Full Text] [Related]
19. Clinical indications for intravenous immunoglobulin utilization in a tertiary medical center: a 9-year retrospective study.
Shemer A; Kivity S; Shoenfeld Y
Transfusion; 2018 Feb; 58(2):430-438. PubMed ID: 29193136
[TBL] [Abstract][Full Text] [Related]
20. IVIg for relapsing-remitting multiple sclerosis: promises and uncertainties.
Bayry J; Hartung HP; Kaveri SV
Trends Pharmacol Sci; 2015 Jul; 36(7):419-21. PubMed ID: 26003802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
